Podcasts about American Academy

This month we are focusing on neonatal opioid withdrawal syndrome (NOWS), with an emphasis on the underlying physiology and clinical presentation. Our host, Paul Wirkus, MD, FAAP and guest Camille Fung, MD review the mechanisms of opioid exposure and withdrawal, including neuroexcitability and the gastrointestinal and autonomic manifestations commonly seen in affected newborns. The discussion also highlights the role of specialized clinics and coordinated care models that support mothers during pregnancy and the postpartum period. Together, this episode provides a foundational understanding of NOWS to help clinicians recognize symptoms early and deliver informed, compassionate care to both infants and their families. Have a question? Email questions@vcurb.com. They will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dr. Robert Rhoton is the Chief Clinical Officer of the Arizona Trauma Institute and President of the Trauma Institute International. A Diplomate of the American Academy of Experts in Traumatic Stress, he has spent decades advancing the understanding and treatment of developmental and family trauma. Dr. Rhoton has supervised outpatient clinics, juvenile justice and substance abuse programs, day treatment centers, and child and family therapeutic services. Formerly a professor at Ottawa University, he trained counselors to work with traumagenic family dynamics using non-egoic, compassionate models of care. Today, he consults with agencies and organizations across the globe, helping them strengthen trauma-informed systems and improve therapeutic outcomes for both individuals and families.In This EpisodeArizona Trauma InstituteBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.You can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSa———If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Thank you to our Sponsors:Jane App - use code GUY1MO at https://jane.appArizona Trauma Institute at https://aztrauma.org/

Send us a textFebruary is National Children's Dental Health Month. To kick it off, I asked David Krol on the podcast to provide an overview of children's oral health. David is former Chair of the American Academy of Pediatrics Section on Oral Health; the lead author of AAP's clinical report, Maintaining and Improving the Oral Health of Young Children; and an eloquent and passionate advocate for children's oral health. In other words, the ideal Talking About Kids guest. More information about David is at talkingaboutkids.com.

Send us a textIn this episode, Dr. Amy Gelfand, a child neurologist specializing in pediatric headaches, discusses the complexities and treatment of migraines in children. Gelfand explains the genetic nature of migraines and their commonality among kids, noting triggers like menstrual cycles and changes in sleep patterns. She elaborates on distinguishing features of migraines and provides insight into preventive and acute treatments, including NSAIDs, triptans, neuromodulation devices, and supplements. The discussion also covers the importance of a regular schedule, the benefits of cognitive behavioral therapy (CBT), and recent advancements in migraine-specific medications. Dr. Gelfand emphasizes the significant progress in migraine treatment and encourages families to consult specialists for personalized care.About Dr Gelfand:Dr. Amy Gelfand is a pediatric neurologist who specializes in diagnosing and treating children with a variety of headache disorders, as well as those with childhood periodic syndromes (such as abdominal migraine), which may be precursors to migraine headache later in life. Her research focuses on the epidemiology of pediatric migraine and childhood periodic syndromes.Gelfand received her medical degree from Harvard Medical School. She completed residencies in pediatrics and child neurology at UCSF.Gelfand has received a teaching award from the UCSF pediatric residency program and writing awards from the medical journal Neurology. She is a member of the American Academy of Neurology, Child Neurology Society and American Headache Society.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...

The Steve Gruber Show | More Taxes, Higher Energy Bills, and Zero Shame—Welcome to Democrat Rule --- 00:00 - Hour 1 Monologue 27:48 – Mary Holland, President and General Counsel of Children's Health Defense. A former law professor and human rights advocate, Holland discusses a lawsuit filed by RFK Jr.'s former organization against the American Academy of Pediatrics. She explains the legal and medical freedom implications for parents and children. 38:03 - Hour 2 Monologue 46:48 – Kristina Rasmussen, Executive Director of Do No Harm. Rasmussen argues that President Trump should do more than just cut federal funding. She explains how redirecting federal dollars could be a powerful tool to push back against harmful policies in healthcare and education. 56:52 – Peter Schweizer, investigative journalist, author, and host of The Drill Down podcast. Schweizer discusses his new book, The Invisible Coup. He breaks down how entrenched power networks operate behind the scenes and what they mean for America's political future. 1:15:30 - Hour 3 Monologue 1:24:21 – Mark Fisk, co-founder and partner of Byrum & Fisk Advocacy Communications. Fisk explains how highlights from the Detroit Auto Show underscore the need for stable and fair trade policy in Michigan. He discusses why long-term certainty is critical for the auto industry and manufacturing jobs. 1:34:33 – Rep. Bradley Slagh, Chair of the Michigan House Corrections and Judiciary Budget Subcommittee. Rep. Slagh discusses why House Republicans are urging the Michigan Supreme Court to reconsider a proposed ICE ban. He explains the legal, public safety, and enforcement concerns surrounding the issue. 1:43:20 – Ivey Gruber, President of the Michigan Talk Network. Gruber reflects on Groundhog Day before shifting to concerns about reports of candies testing positive for arsenic. The discussion also covers the war on sugar, knowing where your food comes from, and speculation about President Trump potentially brokering a deal with Cuba. --- Visit Steve's website: https://stevegruber.com TikTok: https://www.tiktok.com/@stevegrubershow Truth: https://truthsocial.com/@stevegrubershow Gettr: https://gettr.com/user/stevegruber Facebook: https://www.facebook.com/stevegrubershow Instagram: https://www.instagram.com/stevegrubershow/ Twitter: https://twitter.com/Stevegrubershow Rumble: https://rumble.com/user/TheSteveGruberShow

Pálinkás Dániel   Színészélet New Yorkban , őszintén Pálinkás Dániellel ep. 300   Ebben az epizódban egy igazán különleges, útközben rögzített beszélgetésbe csöppenünk bele Pálinkás Dániellel, a fiatal, céltudatos magyar színésszel, aki New York és Magyarország között építi nemzetközi karrierjét. A Patkós, ha Elvis autós podcast keretében Dani őszintén mesél a színészi hivatás valódi arcáról, a karakterépítés belső folyamatairól, valamint arról az útról, amely a budapesti egyetemi évektől az amerikai színpadokig vezetett.   Dani tanulmányait Magyarországon kezdte, majd New Yorkban folytatta a világhírű American Academy of Dramatic Arts falai között. A beszélgetés során betekintést enged abba, hogyan kapcsolódik össze számára a történelem és a színészet, különösen az 1956-os forradalomról szóló színházi darab kapcsán, amelyben jelenleg is szerepel.   Különleges témája az epizódnak Dani egyedi feldolgozása a János vitézből, amelyet egyedül ad elő, vizuálisa   n üvegpoharakkal keltve életre a karaktereket. Elmeséli, hogyan született meg ez a formabontó előadás a Covid-időszak alatt, és miként turnézták vele végig szinte egész Amerikát Los Angelestől San Franciscón át egészen Hawaiig.   Szó esik a színészi fegyelemről, önkritikáról, kitartásról, valamint arról is, milyen lelki erő kell ahhoz, hogy valaki külföldön, idegen nyelven és kultúrában építsen művészi pályát. Dani inspiráló őszinteséggel beszél a kudarcokról, a véletlenek erejéről és arról, hogyan "vonzza be" az élet az új lehetőségeket.   A beszélgetés végén még egy kis New York-hangulat is jut a nézőknek, hiszen a felvétel során elhaladnak a legendás Central Park mellett, miközben a színházi élet kulisszatitkairól mesélnek.   Ez az epizód nemcsak a színház szerelmeseinek szól, hanem mindenkinek, aki hisz az álmokban, a kitartásban és abban, hogy kemény munkával a világ bármely pontjáról el lehet indulni felfelé.  

This week, the American Academy of Pediatrics released its updated vaccine schedule for children, and for the first time in decades, it does not fully align with the CDC's recommendations. All of this comes as the U.S. faces one of the worst flu seasons in recent years. In this Special Edition, we turn to Dr. Céline Gounder, a leading public health expert, physician, and epidemiologist, to help make sense of what's changing and what families should know. We break down what the split between the AAP and CDC actually means for parents, where this flu season stands right now, which symptoms and treatments matter most, and how to think about timing, vaccines, and risk moving forward. We hope this helps you feel more prepared and make more informed decisions for yourself and your family.   Learn more about our guest(s): https://www.theNewsWorthy.com/shownotes Join us again for our 10-minute daily news roundups every Mon-Fri!  Become an INSIDER and get ad-free episodes here: https://www.theNewsWorthy.com/insider Get The NewsWorthy MERCH here: https://www.theNewsWorthy.com/merch Sponsors: Receive 50% off your first order of Hiya's bestselling children's vitamin. To claim this deal, go to hiyahealth.com/NEWSWORTHY. To advertise on our podcast, please email: ad-sales@libsyn.com    

A viral encounter with a bronze sculpture put our host, Madison Beale, in touch with the incomparable interdisciplinary artist Patricia Cronin this year. Today on the Artalogue, Beale sits down down with Cronin to discuss her career trajectory from humble beginnings to a global art world presence as multidisciplinary feminist artist behind Memorial to a Marriage and Shrine for Girls to unpack how a work of art can carry both intimacy and insurgency.Patricia traces her path from a Catholic childhood through the 1990s culture wars, with erotic Polaroids interrogating power, authorship and voyeurism. That same insistence on lived perspective inspired later works, like the three-ton neoclassical embrace installed on her own burial plot to answer legal and physical absence in public space, and three quiet altars in Venice layered with fabrics that invite viewers to better understand how the patriarchy harms us all. Beale and Cronin also face the present head-on: executive orders scaring museum programs into deplatforming artists, show cancellations rippling through the arts in the United States, and the subtler danger of self-censorship in the studio. Cronin shares a clear path for resisting authoritarianism, matching skills to message and building communities that outlast regimes. Patricia Cronin is an interdisciplinary feminist artist that examines issues of gender, sexuality, and social justice. Major bodies of work focus on the international human rights of LGBTQ+ persons, women, and girls, including “Memorial To A Marriage”, the world's first Marriage Equality monument. Cronin's work has been exhibited internationally, with solo exhibitions at institutions including the Tampa Museum of Art, The FLAG Art Foundation, the 56th Venice Biennale, the Brooklyn Museum, and the American Academy in Rome. She has also participated in significant group exhibitions around the world and received  various prestigious awards and fellowships. Cronin's works is collected by numerous museums, including Kelvingrove Art Gallery and Museum, Leslie-Lohman Museum of Gay and Lesbian Art, National Gallery of Art, Perez Art Museum Miami, Smithsonian National Portrait Gallery, Tampa Museum of Art, and Woodlawn Cemetery. She lives and works in Brooklyn, New York.If this conversation moves you, follow the show, share it with a friend who loves art and justice, and leave a review with the artwork that changed your life. Your stories help others find us and keep this community growing. Connect with the Artalogue: Madison Beale, HostBe a guest on The Artalogue Podcast

As Trump surges his Gestapo and threatens to annex new territory, his brain is collapsing. He's sundowning on Truth Social, nodding off in meetings, slurring words, slurping at the saliva pooling in his mouth. His insults and aggressions are as constant and predictable as his arms are, reaching out for handholds. Up until this point, discourse on the mental health of this decrepit fascist leader has used the kid gloves of psychology, psychoanalysis, and psychiatry, in which even the most informed analyses were constrained by the fact that experts were interpreting his inner states. For our part, we've compared his fate to that of charismatic cult leaders at the end of the line—and we'll do more of that today. Now a new posse of clinical commentators on IG and TikTok have made it all much more biological: we are witnessing, they say, the predictable signs of fast-progressing dementia. Show Notes Goldwater Rule vs Duty to Warn, American Academy of Psychiatry and Law World Health Organization: Dementia Signs and Symptoms of Dementia Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges USC study finds new evidence linking dementia to problems with the brain's waste clearance system A new drug could stop Alzheimer's before memory loss begins A 2025 update on treatment strategies for the Alzheimer's disease spectrum Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework Study finds disparities in diagnosis and treatment of dementia Decomposing Racial and Ethnic Disparities in Risk and Protective Factors of Dementia in the U.S. Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review Dementia Diagnosis Disparities by Race and Ethnicity Racial disparities in dementia determined by social factors Straight-forward Explainer: What's Going on With NIH Cuts to Alzheimer's Research? Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Steve Fretzin, Robert Armstrong, and Sandy Fisch discuss:Legal expertise without systems limits growthFocus outperforms expansion without infrastructureValue-based models outperform time-based billing in an AI-driven futureFuture-proof firms are systemized, collaborative, and diversified Key Takeaways:Most firms are built by technicians who understand legal work but not business operations. Sustainable firms require deliberate work on systems, strategy, and management.Deep specialization strengthens results, clarity, and scale. Expanding practice areas too early dilutes effectiveness and increases operational drag.Hourly billing weakens as automation accelerates legal work. Flat-fee pricing combined with strong human relationships aligns better with efficiency and client outcomes.Recurring revenue, acquisition-ready structures, and trusted peer communities reduce dependence on individuals. Long-term resilience comes from systems, relationships, and adaptive business models. "There's a difference between working on the business and working in the business." —  Sandy Fisch Check out my new show, Be That Lawyer Coaches Corner, and get the strategies I use with my clients to win more business and love your career again. Ready to go from good to GOAT in your legal marketing game? Don't miss PIMCON—where the brightest minds in professional services gather to share what really works. Lock in your spot now: https://www.pimcon.org/ Thank you to our Sponsor!Rankings.io: https://rankings.io/ Ready to grow your law practice without selling or chasing? Book your free 30-minute strategy session now—let's make this your breakout year: https://fretzin.com/ About Robert Armstrong: Robert Armstrong is President of the American Academy of Estate Planning Attorneys and co-founder of Armstrong, Fisch & Tutoli, a leading San Diego estate planning firm. A U.S. Navy veteran and summa cum laude graduate of UC San Diego, he earned his Juris Doctor from the University of San Diego in 1976.A recognized thought leader in estate planning, Robert has authored several books, including The E-Myth Attorney, and has been quoted in national publications such as the Wall Street Journal. He frequently appears on television as an estate planning expert.Robert lives in Knoxville, Tennessee, with his wife, Jennifer, and enjoys reading, daily workouts, and time outdoors with his family. About Sandy Fisch: Sanford Fisch is a principal at Armstrong, Fisch & Tutoli, a leading San Diego estate planning firm recognized nationwide for excellence. He co-founded the American Academy of Estate Planning Attorneys to help attorneys and law firms improve their skills and practices.Known for expertise and enthusiasm, Sanford seeks more effective ways to serve clients, support fellow attorneys, and advance the practice of estate planning law across the United States. Connect with Robert Armstrong & Sandy Fisch:  Website: https://www.aftattorneys.com/ Connect with Steve Fretzin:LinkedIn: Steve FretzinTwitter: @stevefretzinInstagram: @fretzinsteveFacebook: Fretzin, Inc.Website: Fretzin.comEmail: Steve@Fretzin.comBook: Legal Business Development Isn't Rocket Science and more!YouTube: Steve FretzinCall Steve directly at 847-602-6911 Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it. 

The Trump administration proposes a modest pay increase for Medicare Advantage plans. The American Academy of Pediatrics releases its updated childhood vaccine schedule. And a platform billed as “ChatGPT for doctors” becomes the most valuable healthcare AI startup. Those stories and more, on today's episode of The Gist Healthcare Podcast. Hosted on Acast. See acast.com/privacy for more information.

Announcements: Rob Palmer with a new video interview, talks with SETI astronomer Seth Shostak @5:59 The February/March issue of Free Inquiry is now available to read online, featuring a new set of articles focused on “The Ongoing Controversy: Was Jesus Real?” Don Wharton kicks things off with “A CERN-Level Proof of Mythicism,” making the argument that Jesus is a mythical figure. @9:32 David W. Falls (“Rethinking Jesus: The Morality and the Myth”) Follow-ups: News: Trump says Alex Pretti should not have carried gun that was allowed under Minnesota law @10:22 Right leaning question @18:16 ICE in Ecuadorian Consulate @26:59 Taliban Introduce New Criminal Code in Afghanistan @28:23 United States has completed its withdrawal from the World Health Organization. @32:38 Health/Medicine/Science: RFK speed round Robert F. Kennedy, Jr. has appointed two new members to the Advisory Committee on Immunization Practices (ACIP). It appears they'll fit right in @36:44 Chair of CDC's vaccine panel questions need for polio vaccines @37:24 No Link Between Acetaminophen in Pregnancy and Autism, a Study Finds @39:05 FDA deletes warning on bogus autism therapies touted by RFK Jr.‘s allies @40:06 Experts Who Advised on Diet Guidelines Say RFK Jr.'s Version Is Full of Errors @40:32 Medical groups' lawsuit attempts to undo the CDC's childhood vaccine schedule changes @41:19 RFK Jr. Links His Vocal Issues to Flu Shots | MedPage Today @41:32 Federal judge orders HHS to restore $12m in funding to American Academy of Pediatrics @43:25 Google removes some AI health summaries @44:06 U.S. measles cases at a 30-year high, Axios charts the current surge while Unbiased Science debunks the popular social media claim that “wild measles protects you from cancer.” @44:52 Religious Nonsense: The National Center for Science Education flags a proposal in the Oklahoma Senate that, “if enacted, would require any public or charter school teacher who teaches evolution also to ‘provide instruction to students on the concepts of creationism and/or intelligent design.'” @46:37 What is Christian Reconstructionism @47:22 Catholicism shrinks in Latin America while more are religiously unaffiliated @49:12 Final Stories: https://cfiig.org/dowsing-for-disease/ @51:42

Clinicians and patients are in a state of prognostic uncertainty when they are unsure about the future course of an illness. By embracing uncertainty while cultivating prognostic awareness, neurologists can serve the critical role of supporting patients and families through the living and dying process. In this episode, Casey Albin, MD, speaks with Robert G. Holloway, MD, MPH, FAAN, author of the article "Managing Prognostic Uncertainty in Neurologic Disease" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Holloway is the Edward and Alma Vollertsen Rykenboer Chair and a professor of neurology in the department of neurology at the University of Rochester School of Medicine and Dentistry in Rochester, New York. Additional Resources Read the article: Managing Prognostic Uncertainty in Neurologic Disease Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello, this is Dr Casey Albin. Today I'm interviewing Dr Bob Holloway about his article on managing prognostic uncertainty in neurologic disease, which appears in the December 2025 Continuum issue on neuropalliative care. Welcome to the podcast, and please introduce yourself to our audience. Dr Holloway: Hi, Casey, and thank you. Again, my name is Bob Holloway. I'm a clinician and neurologist up in Rochester, New York, and I've been doing both neurology and palliative care for many years. Dr Albin: Well, that's fantastic. And I really wanted to emphasize how much I really enjoyed reading this article. I know that we're going to get into some of the pearls that you offer, but I really want to tell the listeners, like, this is a great one to read because not only does it have sort of a philosophical take, but you also really provide some pragmatic tips of how we can help our patients manage this prognostic uncertainty. But maybe just tell us a little bit, what is prognostic uncertainty? Dr Holloway: Yes, thank you. Well, I think everyone has a sense of what prognostic uncertainty is. And it's just the uncertain futures that we as clinicians and our patients face. And I would just say that a way to summarize it is just, how do we manage the "not yet" of neurologic illness? Dr Albin: I love that. In neurologic illness, there is so much "not yet" and there are so many unknowns. And what I thought was really helpful about your article is you kind of give us three buckets in which we can think about the different types of uncertainty our patients are facing. What are those? Dr Holloway: This is, I think, an area that really is of interest to me, thinking about how to organize the prognostic "not yet" or that landscape. And one way I've tried to simplify it is to think about it as data-centered. And that's the world that we mostly live in as neurologists. That's the probability distributions. We also have kind of system-level uncertainties, and that's the uncertainties that our health system affords for our patients. And then we have, also, the patient-centered uncertainties and the uncertainties that those two prior categories cause for our patients. And that's a big uncertainty that we often don't address. Dr Albin: In reading the article, I was really struck by, we spend a lot of time thinking about data uncertainty. Can we get population-based research? Can we sort of look at prognostication scoring? I live in the ICU, and so we think a lot about these, like, scoring metrics and putting patients into buckets and helping us derive their care based on where their severity index is. And I'm sure that is true in many of the divisions of neurology. But what I did not really appreciate---and I thought you did a really fantastic job of kind of drawing our attention to---is there's a lot of system-centered uncertainty. Can you give us a little bit of examples, like, what is system-based uncertainty? Dr Holloway: I think system-level uncertainties just encompass the practical information gaps that may arise during our healthcare encounter. And a lot of, I think, the uncertainty that our patients face and families, they actually describe it as they feel captive by the uncertainty. And it's just the unknowns, not just what affords from the actual information about the disease and its prognosis in the future, but actually the level of the system, like, who's going to take care of them? How do you manage arranging for nurses to come into the home or all those practical-level uncertainties that the system provides that sometimes we don't do a good job of road-mapping for patients. Dr Albin: Absolutely. Because I feel like we have a little bit of a gap in that often as physicians. Like, the family asks, what will hospice at home look like? Well, you know, that's a question for case management. I think they'll come in and they'll tell you. But it strikes me that that's a real gap of my being able to walk patients through. Will they get home health care? Will they have transportation set up? Will there be a nurse who comes in to check? How often are they available? What's the cost going to be? All of these practical aspects of dealing with an illness that are beyond sort of our scope of knowledge, but probably have a huge practical impact to the patient. Dr Holloway: Without question, every encounter patients wonder about, that kind of future wish landscape that we- all our future-oriented desires and hopes. And so much of that is the practical aspects of our health system, which is often fragmented, kind of unknown, uncertain. And that's a huge source of uncertainty for our patients and families. And then that leads to many other uncertainties that we need to address. Dr Albin: Absolutely. I think another one that we, again, maybe don't spend quite as much time thinking about is this patient-level uncertainty. What's going on there? Dr Holloway: Yeah. So, I think patient-level uncertainty is that uncertainty that they experience when confronted with the two other types of uncertainty: the actual data-centered uncertainty and the system-level uncertainty. And that's that, kind of, very huge kind of uncertainty about what it means for them and their family and their future futures. And that's a source of huge stress and anxiety, and often frankly bordering on dread and fear for our patients and families. That actually gets into very levels of uncertainty that I would call maybe over even in the existential realm. Patient-level uncertainty in the actual existential questions or the fear and the dread or the kind of just unnerving aspect of it is actually even more important to patients than the scientific or data-centered uncertainty that we focus most of our attention on. Dr Albin: Yeah, I think this is, to me, was getting towards that, like, what does the patient care about and how are they coping with what is in many times a really dramatic shift in their life expectancy or morbidity expectations and this sort of radical renegotiation about what it means to have a neurologic illness? And how does that shift their thinking about who they are and their priorities in the world? Is that right? Dr Holloway: One thousand percent, and in fact, I will say---and I think is one of the main take home messages is that, you know, managing prognostic certainty is not an end in itself. It really is to help patients and families adaptively cope to their new and often harsh new reality, that we could help them adapt to their new normal. I think that is one of our main tasks as neurologists in our care teams is to help patients find and ultimately maybe achieve existential or spiritual or well-being even in their new health states. You know, that you certainly often see in the intensive care unit, but we often always see in the outpatient realm as well, and all our other diseases. Dr Albin: I think that's really hard to do. I think those conversations are incredibly difficult and trying to navigate where patients want to be, what would bring meaning, what would bring value. I think many of us struggle to have these pretty real and intense conversations with families about what really is important. And one of the things I really liked about this article is you kind of walk us through some steps that we as clinicians can take to get a little bit more comfortable. Maybe just walk us through, what are some of the things that you have found most helpful in trying to get families and patients to open up about what brings them meaning? How are they navigating this new, really uncertain time in their life? Dr Holloway: Yeah, so I do kind of have a ten-point recommendations of how to help cultivate a more integrated awareness of an uncertain future. I mean, I think the most important thing is actually just recognizing that embracing uncertainty as an amazingly remarkable cognitive tool. I mean, let's face it, uncertainty, when it happens with neurologic illness and disease, is often fearful. It's scary. It kind of changes our world. But on the flip side of it, it's a remarkable cognitive tool that actually can help us find new ways and new paths and new creativity. And I think we can use that kind of opposites to help our patients find new meaning in very difficult situations. So, thinking about uncertainty, kind of being courageous, leaning into it and recognizing that it does create anxieties and fear, but it also can kind of help create new solutions and new ideas to help people navigate. Dr Albin: I was hoping that maybe you could give us an example of, like, how would you do that? If a patient comes in and they're dealing with, you know, a new diagnosis and they're navigating this new uncertainty, what are some of the things that you ask to help them reframe that, to kind of take some of the good about that uncertainty? How do you navigate that? Dr Holloway: One of the other recommendations is actually just resetting the timeline and expectations for these conversations. That it shouldn't be expected that patients should accept their harsh new reality immediately, that it takes time in a trusted environment. And that there's this, like, oscillating nature of hopes and fears and dread, and you've just got to work with them over time. And with time, and once you understand who the patient and family are and understand where they find meaning and where they find, actually, joy in their life, or what actually brings them meaning, you can start recasting their futures into credible narratives in their kind of future landscape in ways that I think can help them enter into their new realities within the, you know, framework of disease management that you can offer them within your healthcare team or your healthcare system or wherever you are in the world and the available resources that you have to offer patients and families. Dr Albin: So, this sounds like a lot to me like active listening and really trying to get to know what is important to the family, what is important to the patient. And I guess probably just creating that space even in that busy clinical environment. Do I have that right? Dr Holloway: You can absolutely do that, right. You know, and honestly, active listening, we are challenged in our busy healthcare system to do this, but I think with the right listening skills and the appropriate ways of paying attention, you can definitely illuminate these possible, kind of future-oriented worlds for patients and help them navigate those new terrains with them. Frankly, I think that's a real new space for us in neurology. We don't think about and train how to create credible narratives for patients and families. We do it on the fly, but I think there's so much more work to do. How do you actually keep, you know, that best-case, worst-case, most likely credible narratives for patients that can help them adapt to their new realities and support them on their new journeys? Dr Albin: I love that best-case, worst-case, most likely case. I find that framework really helpful. But you talk in your article, it's not just about using that best case or worst case or most likely, but it's actually building some forecasting into that and having some real data to kind of support what you're saying. And there's a lot of growth towards actually becoming good as a medical forecaster. Can you describe a little bit, what did you mean by that? Dr Holloway: You're absolutely right. I think, actually, one of the skillsets of becoming and managing prognostic uncertainty is actually becoming a skilled medical forecaster. And it's a really tall order. So, we've got to be both good medical forecasters as well as helping patients adaptively cope to their new reality. But the good medical forecasting is actually now going more quantitative in thinking about the data that's available to help think about the important outcomes for patients and families and then predicting what their probabilities are so you can shape those futures around. So, yes, we do have to have an open mindset. We do have to actually look at the data that's available and actually think about, what are those long-term probabilities and outcomes? And we can be honest about those and even communicate them with families. But it's a really good skill set to have. Dr Albin: Yeah. This to me was a little bit about, how do you bring in the data knowledge that we try to get over time as we develop our expertise? You're developing not just a reliance on population-based data, but in my experience, I have seen this. And that sort of ability to kind of look at the patient in front of you, think about the big picture, but also a little bit about their unique medical comorbidities or prior life experiences. So, some of that database knowledge, and then bringing in and getting to know what is important to the patient. And so, sort of marrying that data-centric/patient-centric mindset. Dr Holloway: I love it. I guess the other way of saying that, too, is we need to think with precision, but communicate in narratives. And it's okay to gently put more precise estimates on our probability predictions with patients and families, what we think is the most likely case, best and worst case. Because patients and families want us to be more precise. We often shy away from it, but- so, it's okay to think in precisions, but we've got to put those in narratives in the most likely, best-, and worst-case scenarios. And don't be afraid if you think in terms of ninety percents, ten percents, fifty percents; most patients and families don't mind that. And what they're telling us is they actually want to hear that, if you are comfortable talking in those terms. Dr Albin: Yeah, absolutely. And giving a sense of the humility to say, like, this is my best guess based on medical data and my experience, I would say, but again, none of us have a crystal ball. And I do think families, as long as you're sort of couching your expectations into the sort of imperfect, but I'm doing my best, really appreciate that. Dr Holloway: They totally do all the time. Just say, I simply don't know for certain, but these are my best estimates. That's a good way of just phrasing that. Dr Albin: Yeah. So powerful. I don't know for certain. And then I wanted to just kind of close out, because there's this one term that you use that I thought was so interesting. And I wanted you to kind of tell our listeners a little bit about what you mean here, which is that, when you're actively open-minded, you're using this, quote, "dragonfly eyes." What do you mean by that? Dr Holloway: So, the dragonfly eyes, as you know, they can look at three sixty around them and they just, they move in all directions. Being actively open minded, I guess the biggest example I would say is, I don't like the term prognostic discordance, which means that there's a difference of subjective estimates of prognosis between patients and families. Being openly minded is actually embracing the potential information that the family has about prognosis and incorporating that into your estimates. So, I wouldn't say it's discordances, per se; I think being really actively open-minded is taking that all in and utilizing that as, you know what, they know more than you do about the patient and their loved ones, and they may have insights that can inform your best estimates of prognosis. So, the true dragonfly prognosticator actually is one who embraces and doesn't consider it discord, but considers it kind of new, useful information that I just need to weigh in so I can help the family in my best professional way in terms of developing a prognosis, whatever the condition may be. Dr Albin: I can imagine this is just so challenging and something that takes a long time to sort of perfect all of this. I think you say right below that, you need a growth mindset to do this because it is hard, and it's going to take an active participation and an active desire to get better at these conversations with our families. Dr Holloway: One thousand percent. You are so right that it takes time, effort, and not feeling like you're being challenged, but that actually you are including them in your entire body of knowledge, that you're just- it's part of all you're collecting. And even, I was on service last week, and I talked to residents and students about that very issue. It's like take their prognosis. And someone who came in, we thought CJB, very sad, tragic case, but we were thinking about what the future may look like and how do we actually work with the family who had very what we thought was unrealistic expectations. I said, well, no, this is not discordance. This is just useful information that we can take understand where they're coming from and incorporate that into the ways we want to build relationships, build trust, and over time we'll get to a point where we hopefully can work with them and have them have that fully integrated awareness of their future. Dr Albin: Yeah, that's beautiful. It really is this ongoing negotiation that really requires so much listening, understanding, and then obviously information and expertise about the data that we're presenting and the likelihood outcome, recognizing that there's a lot of uncertainty in all of this. Which, you know, again, this is kind of a 360 talk. At every level there is uncertainty, and that's what makes it so hard. Dr Holloway: Yeah, you're absolutely right. And actually, even in the article I kind of used the term radical uncertainty as that, no matter how resolvable all this uncertainty is, there will always still remain that radical element of our existence which we have to actually incorporate and be prepared for. And actually, not only of ourselves, but actually for patients and families and helping manage that. Using narratives and credible narratives and kind of ranges of possibilities is the best way to do that in a personalized way. Dr Albin: Well, this has been a fantastic conversation, and I know that we are running a bit short on time. So, as we wrap up and you think about this topic, are there any key take-home messages that you hope our listeners will walk away with? Dr Holloway: I think one main emphasis is that despite all the successes we feel we have in neurology, is that we all have to recognize that prognostic uncertainty is just going to increase in the future. But this is going to be for several reasons. One is that, just, the illness uncertainty of all of our great therapies are just going to be creating more uncertainty for the future. And precision medicine is paradoxical, and that actually it creates more uncertainty. So, I think we need to be prepared that we have to manage prognostic uncertainty better, because it's definitely going to increase. And two, it's what I said earlier, is that actually managing prognostic uncertainty is not an end to itself. It's actually helping patients and families adapt to their new and sometimes harsh new reality and actually help them to ultimately get to a place where maybe either their condition is neither dreaded, but actually they can accept it as their new reality and actually achieve some sort of existential well-being and existential health. I think that we have a lot more to emphasize in this area. And for far too long, we've focused on the certainty aspect of our field and not enough on the uncertainty in the world of medicine to help our patients and families. Dr Albin: And gosh, isn't there just so much uncertainty? And I think this has been beautiful. So, thank you again for coming and sharing your expertise. Dr Holloway: Thank you very much. It's been a pleasure. Dr Albin: For all of our listeners out there, this is a truly fantastic article, and I would just like to direct you to going to read the cases because not only do the cases offer a little bit of practical advice, but there's one that's actually sort of a philosophical discussion about, what does it mean to be alive and confront death? There's some beautiful artwork that's featured as well. So this is just a really unique article, and I'm excited for our listeners to have a chance to check it out. So again, today I've been interviewing Dr Bob Holloway about his article on managing prognostic uncertainty in neurologic disease, which appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Welcome back to the office hours with Juan and Frank! We just put on a fresh pot of coffee, so come on in, pour yourself a cup, and grab a seat. In this brief episode we'll discuss a workshop we co-hosted at the American Academy of Audiology 2025 conference in New Orleans. We focused on the value of continuing education for audiologists on the topic of music audiology, and how musicians and audiologists can collaborate to meet their mutual goals, but mostly this episode is an excuse to bring you the music of our in-session house band. They absolutely ruled and that is an evidence-based fact. The band was Ari Teitel (guitar), TJ Norris (bass), and Trenton O'Neal (drums) of the 2x Grammy nominated band The Rumble. They played for about an hour and brought a party atmosphere to what would otherwise be a dry but informative hands-on hearing protection and SPL meter activity.  And we're not done with support audiologists who want to care for musician patients in the best possible manner. If you're attending the National Hearing Conservation Association, come join our 3 hour hands-on workshop Thursday February 5th, 2026 (just make sure you watch the 3 hour on-demand didactic portion so you're fully prepared). We cooked up something truly unique for this conference and I can't to see if it actually works!

As inequality deepens, democratic institutions strain, and climate risk accelerates, it's becoming impossible to ignore a basic question: What is capitalism actually for? This week, we revisit our conversation with Harvard Business School professor Rebecca Henderson who argues that today's economic crises aren't the result of isolated failures, but of an economic system designed around the wrong goal—maximizing shareholder value at any cost. Drawing from her book Reimagining Capitalism in a World on Fire, Henderson makes the case that markets built around cooperation, dignity, and shared prosperity don't just serve the public good—they often outperform extractive, low-road models, while decades of trickle-down economics hollowed out institutions, rewarded cheating over value creation, and left businesses dependent on a society they are actively undermining. Together, they ask what it would take to build a new economic paradigm—one where firms exist to strengthen the communities, democracy, and planet they rely on to survive. Rebecca Henderson is the John and Natty McArthur University Professor at Harvard Business School, where she teaches the acclaimed course Reimagining Capitalism and explores how business can help build a more just, sustainable economy. She is the author of Reimagining Capitalism in a World on Fire, and a research fellow at the National Bureau of Economic Research, a fellow of the British Academy and American Academy of Arts and Sciences, and has served on the boards of major public companies. Social Media: @RebeccaReCap Further reading:  Reimagining Capitalism in a World on Fire TED Talk: To save the climate, we have to reimagine capitalism Website: http://pitchforkeconomics.com Facebook: Pitchfork Economics Podcast Bluesky: @pitchforkeconomics.bsky.social Instagram: @pitchforkeconomics Threads: pitchforkeconomics TikTok: @pitchfork_econ YouTube: @pitchforkeconomics LinkedIn: Pitchfork Economics Twitter: @PitchforkEcon, @NickHanauer Substack: ⁠The Pitch⁠

Monday, January 26, 2026 Trump agreed to “look into reducing the number of federal agents in Minnesota” after a Border Patrol agent killed Alex Pretti, a 37-year-old ICU nurse and U.S. citizen; Trump sent border czar Tom Homan to Minnesota to oversee ICE operations; Senate Democrats threatened to block the House-passed funding package unless Republicans strip out the Department of Homeland Security bill; the CDC's vaccine advisory panel said polio, measles, and possibly all shots should be optional; and the American Academy of Pediatrics told parents to ignore the CDC's revised federal guidance and instead follow its full childhood vaccine schedule. Read more: Day 1833: "Productive." Subscribe: Get the Daily Update in your inbox for free Feedback? Let us know what you think

Dawn Porter is an acclaimed American documentary filmmaker and founder of Trilogy Films, known for her storytelling on social justice, history, and cultural icons. Her celebrated documentaries, including Trapped, John Lewis: Good Trouble, and The Lady Bird Diaries, air on platforms like HBO, Netflix, Amazon, Apple, CNN, PBS and others. Another film from Porter's recent work, Luther: Never Too Much, highlights the life and legacy of Luther Vandross. Produced with Sony Music Entertainment, Jamie Foxx's Foxxhole, and Colin Firth's Raindog Films, this intimate portrayal of the Grammy-winning artist was recently released in theaters and premiered on CNN/MAX on January 1, 2025. Her recent work, The Sing Sing Chronicles won the Best Documentary Emmy at the 46th annual News & Documentary Emmy Awards. Porter's achievements are widely recognized. A three-time Sundance film festival Alum, her film Gideon's Army was nominated for an Emmy and an Independent Spirit Award and won the prestigious Ridenhour Prize as well as the American Bar Association's Silver Gavel Award. Trapped also earned a Silver Gavel, as well as a Peabody Award and the Sundance Special Jury Prize for Social Impact Filmmaking, while John Lewis: Good Trouble won the 2021 NAACP Image Award. She received the Critics' Choice Impact Award in 2022 and Gracie Awards in both 2022 and 2023. Recently, Porter was awarded the National Humanities Medal by former President Joe Biden, elected to the American Academy of Arts & Sciences, and received the IDA Career Achievement Award. Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this Live Greatly podcast episode, Kristel Bauer sits down with Dr. Michael J. Breus, PhD, globally known as The Sleep Doctor™ to discuss tips for high quality sleep, suggestions to overcome jet lag, a look into sleep chronotypes and lots more. Tune in now!  Key Takeaways From This Episode: What sleep chronotypes are and why it matters Suggestions for higher quality sleep How long should you avoid drinks and food before bed? Tips to overcome jet lag ABOUT MICHAEL J. BREUS, PHD: Dr. Michael J. Breus, PhD has the distinction of being a Diplomate of the American Board of Sleep Medicine and a Fellow of The American Academy of Sleep Medicine. He is one of only 168 people in the world to have passed the Sleep Medical Speciality board without going to Medical School. World-renowned as The Sleep Doctor™, he is a bestselling author, media personality, keynote speaker, and brand advisor, bringing science-backed sleep expertise to the public for nearly three decades.   Connect with Dr. Breus: Website: https://sleepdoctor.com/  Chronotype Quiz: https://sleepdoctor.com/pages/chronotypes/chronotype-quiz?srsltid=AfmBOooagcc1iKsFRmwg-AvEWuA2Jspu2dCOyVr4pxvycenQTO8JLgPU   Instagram: @thesleepdoctor LinkedIn: Michael J. Breus, PhD About the Host of the Live Greatly podcast, Kristel Bauer: Kristel Bauer is a corporate wellness and performance expert, keynote speaker and TEDx speaker supporting organizations and individuals on their journeys for more happiness and success. She is the award-winning author of Work-Life Tango: Finding Happiness, Harmony, and Peak Performance Wherever You Work (John Murray Business November 19, 2024). With Kristel's healthcare background, she provides data driven actionable strategies to leverage happiness and high-power habits to drive growth mindsets, peak performance, profitability, well-being and a culture of excellence. Kristel's keynotes provide insights to "Live Greatly" while promoting leadership development and team building. Kristel is the creator and host of her global top self-improvement podcast, Live Greatly. She is a contributing writer for Entrepreneur, and she is an influencer in the business and wellness space having been recognized as a Top 10 Social Media Influencer of 2021 in Forbes. As an Integrative Medicine Fellow & Physician Assistant having practiced clinically in Integrative Psychiatry, Kristel has a unique perspective into attaining a mindset for more happiness and success. Kristel has presented to groups from the American Gas Association, Bank of America, bp, Commercial Metals Company, General Mills, Northwestern University, Santander Bank and many more. Kristel's work has been featured in Forbes and she has had multiple TV appearances including NBC News Daily, ABC News Live, FOX Weather, ABC 7 Chicago, WGN Daytime Chicago and more. Kristel lives in the Chicago, IL area and she can be booked for speaking engagements worldwide. To Book Kristel as a speaker for your next event, click here. Website: www.livegreatly.co  Follow Kristel Bauer on: Instagram: @livegreatly_co  LinkedIn: Kristel Bauer Twitter: @livegreatly_co Facebook: @livegreatly.co Youtube: Live Greatly, Kristel Bauer To Watch Kristel Bauer's TEDx talk of Redefining Work/Life Balance in a COVID-19 World click here. Click HERE to check out Kristel's corporate wellness and leadership blog Click HERE to check out Kristel's Travel and Wellness Blog Disclaimer: The contents of this podcast are intended for informational and educational purposes only. Always seek the guidance of your physician for any recommendations specific to you or for any questions regarding your specific health, your sleep patterns changes to diet and exercise, or any medical conditions.  Always consult your physician before starting any supplements or new lifestyle programs. All information, views and statements shared on the Live Greatly podcast are purely the opinions of the authors, and are not medical advice or treatment recommendations.  They have not been evaluated by the food and drug administration.  Opinions of guests are their own and Kristel Bauer & this podcast does not endorse or accept responsibility for statements made by guests.  Neither Kristel Bauer nor this podcast takes responsibility for possible health consequences of a person or persons following the information in this educational content.  Always consult your physician for recommendations specific to you.

As the mother of a 28-year-old daughter with autism and legal guardian of her older brother with autism, Alison Singer is a natural advocate for Autism and everything surrounding it. She started the Autism Science Foundation in 2009. She also has  served on the federal Interagency Autism Coordinating Committee (IACC) for 12 years, where she chaired the Safety and Housing Workgroups, and served on the subcommittee responsible for writing an annual strategic plan to guide federal spending for autism research and participated in many of the most important Autism organizations.  In 2012, the American Academy of Pediatrics named her an “autism champion.” In 2017 she received the INSAR “Outstanding Research Advocate” award and in 2018 she received the New York Families for Autistic Children Research Advocacy Award. Autism: When people refer to “Autism,” they are usually talking about Autism Spectrum Disorder (ASD), a brain-based disorder that is characterized by social-communication challenges and restricted and repetitive behaviors, activities and interests. Autism is about four times more likely to affect boys than girls, and is found in all racial, ethnic, and social groups. There is no known single cause of autism, although the best available science indicates a genetic origin. Alison talks about signs to look for, support from various places, effects on family life, and so much more. You can find Alison and information at www.AutismSciencefoundation.org Website: www.heatherthomson.com Social Media: IG: https://www.instagram.com/iamheathert/                     You Tube: https://youtube.com/@iamheathert?si=ZvI9l0bhLfTR-qdo SPONSOR:  AirDoctorPro - Head to www.AirDoctorPro.com and use promo code HEATHER to get UP TO $300 off today! AirDoctor comes with a 30-day money back guarantee, plus a 3-year warranty—an $84 value, free! Get this exclusive, podcast-only offer now! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this Q&A episode, Host Paul Wirkus, MD, FAAP and Ophthalmologist Mitchell Strominger, MD address common clinical questions related to pediatric red eye presentations. The discussion covers key elements of the differential diagnosis, including how to approach cloudy corneas and other concerning findings. We also review practical questions pediatricians frequently encounter, such as whether massage is effective for clearing duct obstruction and important considerations for contact lens use in children and adolescents. This episode offers clear, practical guidance to support safe evaluation, counseling, and management of pediatric eye concerns. Have a question? Email questions@vcurb.com. We will have a new topic next week.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Academy of Pediatrics (AAP) is once again rebuking childhood vaccine guidance issued by the federal government. On Monday, the AAP published its recommended immunization schedule. It includes vaccines for a number of illnesses that the Centers for Disease Control and Prevention (CDC) dropped in recent weeks — illnesses like hepatitis A and hepatitis B, respiratory syncytial virus (RSV), influenza, and more. This is the second time in recent months that pediatricians are taking a stand against the CDC and Health and Human Services Secretary Robert F. Kennedy. The group has called the federal recommendations "dangerous." This hour, we talk with local pediatrician Dr. Elizabeth Murray about what the science says and what parents and caregivers need to know. Our guests: Elizabeth Murray, D.O., pediatrician at Golisano Children's Hospital at UR Medicine Geoffrey A. Weinberg, M.D., professor of pediatrics, and clinical director of the Pediatric Infectious Diseases and Pediatric HIV Program at Golisano Children's Hospital at UR Medicine Connections is supported by listeners like you. Head to our donation page to become a WXXI member today, support the show, and help us close the gap created by the rescission of federal funding.---Connections airs every weekday from noon-2 p.m. Join the conversation with questions or comments by phone at 1-844-295-TALK (8255) or 585-263-9994, email, Facebook or Twitter. Connections is also livestreamed on the WXXI News YouTube channel each day. You can watch live or access previous episodes here.---Do you have a story that needs to be shared? Pitch your story to Connections.

Host Jason Blitman is joined by acclaimed author George Saunders who talks about his new novel, Vigil. Conversation highlights include:

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about how someone typically catches a cold, the flu shot preventing you from getting really sick, the American Academy of Pediatrics departing from the CDC with childhood vaccine revisions, and colorectal cancer now being the leading cause […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about how someone typically catches a cold, the flu shot preventing you from getting really sick, the American Academy of Pediatrics departing from the CDC with childhood vaccine revisions, and colorectal cancer now being the leading cause […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about how someone typically catches a cold, the flu shot preventing you from getting really sick, the American Academy of Pediatrics departing from the CDC with childhood vaccine revisions, and colorectal cancer now being the leading cause […]

Dawn Porter is an acclaimed American documentary filmmaker and founder of Trilogy Films, known for her storytelling on social justice, history, and cultural icons. Her celebrated documentaries, including Trapped, John Lewis: Good Trouble, and The Lady Bird Diaries, air on platforms like HBO, Netflix, Amazon, Apple, CNN, PBS and others. Another film from Porter's recent work, Luther: Never Too Much, highlights the life and legacy of Luther Vandross. Produced with Sony Music Entertainment, Jamie Foxx's Foxxhole, and Colin Firth's Raindog Films, this intimate portrayal of the Grammy-winning artist was recently released in theaters and premiered on CNN/MAX on January 1, 2025. Her recent work, The Sing Sing Chronicles won the Best Documentary Emmy at the 46th annual News & Documentary Emmy Awards. Porter's achievements are widely recognized. A three-time Sundance film festival Alum, her film Gideon's Army was nominated for an Emmy and an Independent Spirit Award and won the prestigious Ridenhour Prize as well as the American Bar Association's Silver Gavel Award. Trapped also earned a Silver Gavel, as well as a Peabody Award and the Sundance Special Jury Prize for Social Impact Filmmaking, while John Lewis: Good Trouble won the 2021 NAACP Image Award. She received the Critics' Choice Impact Award in 2022 and Gracie Awards in both 2022 and 2023. Recently, Porter was awarded the National Humanities Medal by former President Joe Biden, elected to the American Academy of Arts & Sciences, and received the IDA Career Achievement Award. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week's episode is sweeping, interesting, and passionate. Guest Andre Dubus III takes us on a ride through some of memoir's more confounding territory—what's yours to tell; considerations of harm; writing about violence; and getting to truth on the page. Also, Grant has a new book out, and we talk about his book trailer in this week's episode. Watch here.Andre Dubus III has authored nine books including the New York Times' bestsellers House of Sand and Fog, The Garden of Last Days, and his memoir, Townie. His most recent novel, Such Kindness, was published in June 2023, and a collection of personal essays, Ghost Dogs: On Killers and Kin, was published in March 2024. Dubus has been a finalist for the National Book Award, and has been awarded a Guggenheim Fellowship, The National Magazine Award for Fiction, three Pushcart Prizes, and is a recipient of an American Academy of Arts and Letters Award in Literature. He teaches at the University of Massachusetts Lowell. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's been nearly ten years since Britain voted to leave the European Union. The run-up to the referendum was marked by competing claims regarding the consequences of Brexit, with Leave supporters claiming Brexit would restore British sovereignty over economic and social policies, while Remain advocates warned of self-inflicted economic harm. What have the actual consequences of Brexit been? And what lessons does it offer for nations seeking to disengage from the global economy today? Nicholas Bloom joins EconoFact Chats to discuss his recent research on these questions. Nick is the William D. Eberle Professor in Economics at Stanford. He is also the Co-Director of the Productivity, Innovation and Entrepreneurship program at the National Bureau of Economic Research, and a Fellow of the American Academy of Arts and Sciences.

House Republicans break ranks in droves and vote with democrats to squeeze $16B of earmarks and garbage into the budget bill due next week, exposing their deep state true colors. Tim Walz asks for money for his legal defense and the American Academy of Pediatrics is being sued for lying to America's parents about the vaccine schedule and the safety of the shots they require of America's children. Steve Hartman returns to a child's lemonade stand for the sweetest of updates.

In the second episode of this two-part series, Drs. Justin Abbatemarco, Valérie Biousse, and Nancy J. Newman discuss the risk of non-arteritic ischemic optic neuropathy and how to counsel patients around GLP-1 medications.  Show transcript:  Dr. Justin Abbatemarco: Hello and welcome back. This is Justin Abbatemarco again with Valarie Biousse and Nancy Newman talking about non-arteritic ischemic optic neuropathy. I think the other major point that we had a discussion in the podcast was around the GLP-1 medications, which you mentioned have been truly life-changing for diabetes management and obesity. Can we talk about the risk of non-arteritic ischemic optic neuropathy and how you're counseling patients around this class of medications? Dr. Nancy J. Newman:  Absolutely. This is probably one of the most difficult things we are dealing with because it is something that is in process and progress right now. We don't have all the information yet, but it would appear that there is likely a small association of about slightly less than two times risk in patients who are taking these medications of having NAION with a resultant still very, very small overall risk. And it is not necessarily causal. This has prompted the European Medicines Agency to say that these patients should have their GLP-1 RAs stopped if they have NAION. Our own FDA and certainly the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society have not taken that step, but have suggested that this be shared decision-making, not only with the person who makes this diagnosis of an NAION in the patient, but with their primary care doctor or the provider who has felt that a GLP-1 receptor agonist is important for this patient's treatment and health. Dr. Justin Abbatemarco: More to come. We're going to have you back to have discussions as we learn more and better understand the disease and how we help our patients with both their diagnosis and treatment. Thank you so much for your time. 

This member-driven podcast is a benefit of membership of the Arizona Chapter of the American Academy of Pediatrics (AzAAP) and is intended for AzAAP pediatric healthcare members. No information or content in this podcast is intended to substitute or replace a consultation with a healthcare provider or specialist. All non-healthcare providers should reach out to their child's pediatrician for guidance. Music: Wallpaper by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/4604-wallpaperLicense: http://creativecommons.org/licenses/by/4.0/ 

I play some audio from the WEF and describe the larger plan on how the WEF has been dismantled right in front of their own faces; I play current political reaction from two corrupt board members; and a RICO lawsuit against the American Academy of Pediatrics has real weight. Lawsuit toward the AAP:  https://www.skirsch.com/covid/legal/AAP.pdf   Book Websites: HERE and HERE. https://www.moneytreepublishing.com/shop PROMO CODE: “AEFM” for 10% OFF, or https://armreg.co.uk PROMO CODE: "americaneducationfm" for 15% off all books and products. (I receive no kickbacks).  https://www.thriftbooks.com/ Q posts book: https://drive.proton.me/urls/JJ78RV1QP8#yCO0wENuJQPH

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Benjamin Tolchin, MD, MS, FAAN, joins the podcast to provide clinical perspective on the recently published American Academy of Neurology (AAN) guidelines on functional seizures, drawing on his role as a contributing author to the recommendations. Tolchin, Director of the Center for Clinical Ethics at Yale New Haven Health and Associate Professor of Neurology at Yale School of Medicine, discusses what prompted the development of the first AAN guideline in this space and how the evidence base evolved to support formal recommendations. The conversation explores key considerations around diagnosing functional seizures, including history, semiology, EEG use, and the growing role of video documentation. Tolchin also addresses how clinicians should approach psychiatric comorbidities and co-occurring epilepsy, the evidence supporting psychological interventions, why pharmacologic therapies are not recommended for functional seizures themselves, and where major gaps remain in research to advance care in the years ahead.Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page.Episode Breakdown: 1:10 – Why growing evidence prompted the first AAN guideline on functional seizures 3:20 – Diagnostic priorities including history, semiology, EEG, and video documentation 6:15 – Assessing psychiatric comorbidities and co-occurring epilepsy in functional seizures 9:15 – Neurology News Minute 11:30 – Evidence supporting psychotherapy for functional seizures 14:50 – Pharmacological evidence and use of antiseizure medications for functional seizures 18:35 – Barriers to advancing clinical trials in functional seizures 22:05 – Research priorities to refine treatment and long-term outcomes The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Podcast summary of articles from the November 2025 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include pediatric intussusception, d-dimer in aortic dissection, ketamine for pain control, coronary CTA, immune checkpoint inhibitors, and stellate ganglion blocks.  Guest speaker is Dr. Eric Lewis.

Beyond the Digest are bonus episodes to the DermSurgery Digest that include reviews of interesting and relevant articles from JAMA Dermatology, Journal of the American Academy of Dermatology (JAAD) and Plastic and Reconstructive Surgery (ASPS).Articles featured in this episode include: ·        “The efficacy and adverse reactions of 755 nm picosecond alexandrite laser on the treatment of nevus of Ota at different endpoints: A split-lesion, single-blinded, randomized controlled comparison study” in JAAD·        “Economic and environmental benefits of greening a Mohs surgery clinic: A comprehensive intervention and analysis” in JAAD·        “Safety of rituximab in Mohs micrographic and dermatologic surgery: A retrospective cohort study” in JAAD·        “Impact of clinical factors and surgical treatments on sebaceous carcinoma patients with and without Muir-Torre syndrome” in JAAD·        “Disparities in survival and tumor characteristics in patients with single and multiple primary Merkel cell carcinomas” in JAAD·        “Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes” in JAAD·        “Laser hair removal in patients with polycystic ovarian syndrome and darker skin: A retrospective study” in JAAD·        “Efficacy of 0.25% timolol gel in healing surgical open wounds: A randomized clinical trial” in JAAD Beyond the Digest Contributors include Naomi Lawrence, MD, Dermatologic Surgery Digital Content Editor; Yesul Kim, MD, Beyond the Digest Co-host; Kavita Darji, MD; Ami Greene, MD; Caresse Gamret, MD; Tara Jennings, MD; Payvand Kamrani, DO; Sydney Proffer, MD, MS; Kathryn Shahwan, MD; Yssra Soliman, MD Your feedback is encouraged. Please contact communicationstaff@asds.net.

Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comFind out how the future of AI could impact your retirement during Zach Abraham's free “New Year Reset” live webinar January 29th 3:30pm Pacific. Register at KnowYourRiskPodcast.com.Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeYou wouldn't believe the excuse a judge has used to allow pharma to continue to harm your kids...Episode Links:Aaron Siri: "They reported two children died of measles in Texas recently. We represent one of those families. That child did not die of measles. We have all the medical records… The other child we don't represent but… that also wasn't measles."“The judge said the American Academy of Pediatrics can sue RFK Jr. to block the revised vaccine schedule because its members will have to talk more about vaccines with patients, harming their financial interests.”Doctors STILL telling patients: "You're NOT vaccine injured!"  Former CDC Director Dr. Robert Redfield: "We don't have a lot of honesty about vaccine injury. I spend my clinical time on long COVID patients with vaccine injury from the mRNA vaccines."WATCH: Peter Hotez tells woman her repeated COVID infections are basically her fault for skipping boosters.Bill Maher Delivers a Brutal Message to the COVID “Experts” Who Got It Wrong

Dr. Sophie Bakri is the Chair of the Department of Ophthalmology at Mayo Clinic. She joins us today to share take aways from the recent annual meeting of the American Academy of Ophthalmology.  Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and IG: @mayocliniceye 

What is it about architecture that celebrates longevity? The world's most famous architect, Frank Gehry, was actively at work until his death at age 96, finishing his Guggenheim Museum in Abu Dhabi and still designing the greatest works of his career. Masters Frank Lloyd Wright and Phillip Johnson also worked into their 90s and were even more prolific than Gehry. In this special series, Century Lives introduces Victoria Newhouse, a renowned architectural historian. At age 87, Victoria chats with her contemporaries: the late Frank Gehry, Rem Koolhaas, Moshe Safdie, Peter Eisenman, and Raj Rewal—all renowned architects and all in their 80s and 90s. In this episode, Victoria Newhouse talks with 93-year-old architect, theorist and professor Peter Eisenman, who holds a place in architectural history as one of the New York Five, and the founder of Deconstructivism. He's the recipient of the Gold Medal from the American Academy of Arts and Letters. And he has made a lifelong commitment to teaching, serving on the faculty of Yale, Princeton, Harvard, Cooper Union and Cambridge. He now teaches at Cornell University in Manhattan, where he plans to adapt his newest course on the genealogy of architecture as the subject of his 28th book.

Pediatric neuropalliative medicine is an emerging area of subspecialty practice that emphasizes the human experience elements of serious neurologic illness. Child neurologists care daily for patients who can benefit from the communication strategies and management practices central to pediatric neuropalliative medicine, whether at the primary or subspecialty level. In this episode, Gordon Smith, MD, FAAN, speaks with Lauren Treat, MD, author of the article "Neuropalliative Medicine in Pediatric Neurology" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Treat is an associate professor in the divisions of child neurology and palliative medicine at the University of Colorado School of Medicine in Aurora, Colorado. Additional Resources Read the article: Neuropalliative Medicine in Pediatric Neurology Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @gordonsmithMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Smith: This is Gordon Smith. Today I've got the great pleasure of interviewing my good friend Dr Lauren Treat about her article on neuropalliative medicine in pediatric neurology practice. This article appears in the December 2025 Continuum issue on neuropalliative care. Lauren, welcome to the Continuum podcast, and maybe you can introduce yourself to our listeners. Dr Treat: Such a delight to be here, Gordon. Thank you. I am a pediatric neurologist and palliative medicine doctor at the University of Colorado, Children's Hospital Colorado, and I am practicing in both areas. I do general child neurology, and I also run a pediatric neuropalliative medicine clinic. So, I'm happy to be here to talk about it. Dr Smith: And, truth in advertising, I tried very hard to get Dr Treat to move to VC to work with me. And I haven't given up yet. I'm looking forward to the conversation. And Lauren, I wonder- one, I'm really excited about this issue, by the way. This is the second podcast I've done. And I'd like to ask the same question I asked of David Oliver, who's amazing. What a great article and conversation we had. And that question is, can you define palliative care? I think a lot of people think of it as, like, end-of-life care or things like that. And is the definition a little different in the pediatric space than it is in the adult space? Dr Treat: Such a great place to start, Gordon. I absolutely think that there are nuances that are very important in pediatrics. And we especially acknowledge in pediatrics that there is a very longitudinal component of this. And even moreso, I think, then in adult neuropalliative medicine, in pediatrics, we are seeing people=even prenatally or early in their first hours and days of life, and walking with them on a journey that might last days or weeks, but might last years or decades. And so, there is this sense that we are going to come alongside them and be part of the ups and the downs. So yes, neuropalliative medicine is a kind of medicine that is a very natural partner to where neurology is in its current field. We're doing a lot of exciting things with modifying diseases, diagnosing things early, and we have a very high reliance on the things that we can measure in medicine. And not all things can be measured that are worthwhile about one's quality of life. A family very poignantly told me very recently, making sure someone stays alive is different from making sure they have a life. And that's what neuropalliative medicine is about. Dr Smith: Well, great summary, and I definitely want to follow up on several aspects of that, but there's one point I was really curious about as I've been thinking about this, you know, these are really exciting times and neurology in general and in child neurology in particular. And we've got all of these exciting new therapies. And as you know, I'm a neuromuscular person, so it's hard not to think back on SMA and not be super excited. And so, I wonder about the impact of these positive developments on the practice of neuropalliative care in kids. You know, I'm just thinking, you know, you mentioned it's a journey with ups and downs. And I wonder, the complexity of that must be really interesting. And I bet your job looks different now than it did seven or eight years ago. Dr Treat: That's absolutely true. I will self-reference here one of the figures in the paper. Figure 2 in my section is about those trajectories, about how these journeys can have lots of ups and downs and whether this person had a normal health status to begin with or whether they started out life with a lot of challenges. Those ups and downs inherently involve a lot of uncertainty. And that's where palliative medicine shines. Not because we have the answer---everyone would love for us to have the answer---but because we consider ourselves uncertainty specialists in the way that we have to figure out what do we know, what can we ground ourselves in, and how can we continue to move forward even if we don't have all the answers? That is a particular aspect of neurology that is incredibly challenging for families and clinicians, and it can't stand as a barrier to moving forward and trying to figure out what's best for this child, what's best for this family. What do we know to be true about them as people, and how can we integrate that with all of the quantitative measures that we know and love in neurology? Dr Smith: So, I love the comment about prognostication, and this really ties into positive uncertainty or negative undercertainty in terms of therapeutic development. I wonder if you can talk a little bit about your approach to prognostication, particularly in a highly fluid situation. And are there pearls and pitfalls that our listeners should consider when they're discussing prognosis for children, particularly maybe young children who have severe neurological problems? Dr Treat: It's such a pivotal issue, a central issue, to child neurology practice. Again, because we are often meeting people very, very early on in their journey---earlier than we ever have before, sometimes, because of this opportunity to have a diagnosis, you know, prenatally or genetically or whatever else it is---sometimes we are seeing the very early signs of something as compared to previously where we wouldn't have a diagnosis until something was in its more kind of full-blown state. This idea of having a spectrum and giving people the range of possible outcomes is absolutely still what we need to do. However, we need to add on another skill on top of that in helping people anchor into what feels like the most likely situation and what the milestones are going to be in the near future, about how we're going to walk this journey and what we'll be on the lookout for that will help us branch into those different areas of the map down the road. Dr Smith: So, I wonder if we can go back to the framework you mentioned, two answers ago, I think? You and the article, you know, provide four different types of situations kind of based on temporal progression. I wonder if maybe the best way of approaching is to give an example and how that impacts your thoughts of how you manage a particular situation. Dr Treat: Absolutely. So, this figure in particular is helpful in multiple ways. One is to just give a visual of what these disease trajectories are doing, because we're doing that when and we take a history from a patient. But actually, to put it into an external visual for yourself, for your team, but also perhaps for the family can be really powerful. It helps you contextualize the episode of care in which you're meeting the family right now. And it also helps, sometimes, provide some sense of alignment or point out some discrepancies about how you're viewing that child's health and quality of life as compared to how the family might be viewing it. And so, if you say, you know, it sounds like during those five years before we met, you were up here, and now we find ourselves down here, and we're kind of in the middle of the range of where I've seen this person's health status be. Do I have that right? Families feel really seen when you do that and when you can get it accurately. And it also invites a dialogue between the two parties to be able to say, well, maybe I would adjust this. I think we had good health or good quality of life in this season. But you're right, it's getting harder. It's kind of that "show, don't tell" approach of bringing together all the facts to put together the relative position of where we are now in the context of everything they've been through. Dr Smith: You know, I wonder if you could talk a little bit more about the differences between palliative care and adult patients and in children? Dr Treat: Absolutely. One of the key features in pediatrics is this kind of overriding sense of an out-of-order event in the family's life. Children are not supposed to have illness. Children are not supposed to have disability. Children are not supposed to die before their parents. And that layer of tragedy is incredibly heavy and pervasive. It's not every encounter that you have in child neurology, but it does kind of permeate some of the conversations that neurologists have with their patients, especially patients who have serious neurological disease. So that could be things like epileptic encephalopathies, birth injuries, other traumatic brain injuries down the line. In the paper, I'd go through many different categories of the types of conditions that are eligible for pediatric neuropalliative medicine, that kind of support. When we think about that layer of tragedy in the relation to where we're meeting these families, they deserve extra support, not just to think about the medicines and the treatments, but also, what can we hope for? How can we give this child the best possible life in whatever circumstance that they're in? How can we show up in whatever medical decision-making circumstances present themselves to us and feel like we've done right by this child? It's a complex task, and pediatric neural palliative medicine is evolving to be able to be in those spaces with families in a very meaningful way. Dr Smith: So, of course, one of the differences is the, you know, very important role of parents in the situation, right? Obviously, parents are involved in adult palliative care issues and family is very important. But I wonder if you can talk about specific considerations given the parent-child relationship? Dr Treat: So, pediatric neuropalliative medicine really helps facilitate discussions not just about, again, those things that we have data on, but also about what is meaningful and foundational for those families. What's possible at home, what's possible in the community. In pediatrics, parents are making decisions on behalf of their child, often as a dyad, and I don't think this gets enough attention. We know from adult literature that making decisions on behalf of someone else is different from making decisions on behalf of oneself. We call this proxy decision-making. And proxies are more likely to be conservative on behalf of someone else than they are on behalf of themselves, and they're also more likely to overestimate the tolerability of a medical intervention. So, they might say, I wouldn't want this, or, I wouldn't accept this risk on behalf of myself, or, I don't think I'd want to have to persevere through something, but on behalf of this other person, I think they can do it or I will help them through it or something else like this, or, I can't accept the risk on behalf of them. So that's not good or bad. That's just different about making a decision on behalf of oneself as compared to making a decision on behalf of someone else. When there's two people trying to be proxies on behalf of a third person, on behalf of a child, that's a really, really complex task, and it deserves support. And so, pediatric neural palliative medicine can function, then, as this neutral space, as this kind of almost coaching opportunity alongside the other medical doctors to give parents an opportunity when their minds are calm---not in the heat of the moment---to talk about how they see their child, how they've shown up themselves, what they've seen go well, what they've struggled with. And how,, then we can feel prepared for future decision making times, future high-stress encounters, about what will be important to ground them in those moments, even though we can't predict fully what those circumstances might be. Dr Smith: It sounds, you know, from talking to you and having read the article, that these sorts of issues evolve over time, right? And you have commented on this already from your very first answer. And you do describe a framework for how parents think---their mental model, I guess---of, you know, a child with a serious illness. And this sounds like appreciation of that's really important in providing care. Maybe you can talk us through that topic? Dr Treat: I refer to this concept of prognostic awareness in all of the conversations that we have with families. So, what I mean by prognostic awareness is the degree of insight that an individual has about what's currently happening with their child and what may happen in the future regarding the disease and/or the complications. And when we meet people early on in their journey, often their prognostic awareness, that sense of insight about what's going on, can be limited because it requires lived experience to build. Oftentimes time is a factor in that, we gain more lived experience over time, but it's not just time that goes into building that. It's often having a child who has a complication. Sometimes it's experiencing a hospitalization. That transfer from a cognitive understanding of what's going on, from a lived experience about what's going on, really amplifies that prognostic awareness, and it changes season by season in terms of what that family is going through and what they're willing to tolerate. Dr Smith: You introduced a new term for me, which is hyper-capableism. Can you talk about that? I found that really interesting and, you know, it reminds me a lot of the epiphanies that we've had about coma and coma prognosis. So, what's hyper-capableism? Dr Treat: Yes. In neurology, we have to be very aware of our views on ableism, on understanding how we prognosticate in relation to what we value about our abilities. And hyper-capableism refers to someone who feels very competent both cognitively and from a motor standpoint and fosters that sense of value around those two aspects to a high degree. I'm referencing that in the article with regard to medicine, because medicine, the rigors of training, the rigors of practice, require that someone has mental and motor fortitude. That neurology practice and medical practice in general can breed this attitude around the value of skills in both of those areas. And we have to be careful in order to give our patients and families the best care, to not overly project our values and our sense of what's good and bad in the world regarding ableism. Impairments can look different in different social contexts. And when the social context doesn't support an impairment, that's where people struggle. That's where people have stigma. And I think there's a lot of work that we can do in society at large to help improve accommodations for impairment so that we have less ableism in society. Dr Smith: Another term that I found really interesting kind of going back to parents is the "good parent identity." Maybe you can talk about that? Dr Treat: Good parent identity, good parent narrative, is something that is inherent to the journey when you're trying to take care of and make decisions on behalf of a child. And whether you're in a medical context or outside of a medical context, all parents have this either explicit or implicit sense of themselves about what it means to do right by their child. This comes up very poignantly in complex medical conditions because there are so many narratives about what parents ought to do on behalf of their child, and some of those roles can be in tension with one another. It's a whole lot of verbs that often fall under that identity. It's about being able to love and support and take good care of and make good decisions on behalf of someone. But it's also about protecting them from harm and treating their pain and being able to respond to them and know their cues and know these details about them. And you can't, sometimes, do multiple of those things at once. You can't give them as much safety and health as possible and also protect them from pain and suffering when they have a serious illness, when they need care in the hospital that might require a treatment that might be invasive or burdensome to them. And so, trying to be a good parent in the face of not being able to fulfill all those different verbs or ideas about what a good parent might do is a big task. And it can help to make it an explicit part of the conversation about what that family feels like their good parent roles might be in a particular situation. Dr Smith: I want to shift a little bit, Lauren, that's a really great answer. And just, you know, listening to you, your language and your tongue is incredibly positive, which is exciting. But, you know, you have talked about up and downs, and I wanted you to comment on a quote. I actually wrote it down, I'm going to read it to you, because you mentioned this early on in your article: "the heavy emotional and psychological impacts of bearing witness to suffering as a child neurologist." I think all of us, no matter how excited we are about all the therapeutic development, see patients who are suffering. And it's hard when it's a child and you're seeing a family. I wonder if you could talk a little bit about that comment and how you balance that. You're clearly- you're energized in your career, but you do have to bear witness to suffering. Dr Treat: You're right. Child neurologists do incredible work, it's an incredible, exciting field, and there are a lot of challenges that we see people face. And we see it impacts their lives in really intense ways over the course of time. We bear witness to marriages that fall apart. We bear witness to families that lose jobs or have to transition big pieces of their identity in order to care for their children. And that impacts us. And we hold the collective weight of the things that we are trying to improve but sometimes feel less efficacious than we hoped that we could around some of these aspects of people's lives. And so, pediatric neuropalliative medicine is also about supporting colleagues and being able to talk to colleagues about how the care of the patients and the really real effort that we exert on their behalf and the caring that we have in our hearts for them, how that matters. Even if the outcome doesn't change, it's something that matters for our work and for our connections with these families. It's really important. Dr Smith: I wonder, maybe we can end by learning a little bit about your journey? And maybe this is your opportunity to- I know we have students and residents who listen to us, and junior faculty. I think neuropalliative care is obviously an important issue. There's a whole Continuum issue on it---no pun intended---but what was your journey, and maybe what's your pitch? Dr Treat: I'm just going to give a little bit of a snippet from a poem by Andrea Gibson, who's a poet, that I think speaks really clearly to this. They say a difficult life is not less worth living than a gentle one. Joy is simply easier to carry than sorrow. I think that sums these things up really well, that we find a lot of meaning in the work that we do. And it's not that it's easier or harder, it's just that these things all matter. I'm going to speak now, Gordon, to your question about how I got to my journey. When I went into pediatrics and then neuro in my training, I have always loved the brain. It's always been so crucial to what I wanted to do and how I wanted to be in the world. And when I was in my training, I saw that a lot of the really impactful conversations that we were having felt like we left something out. It felt like we couldn't talk about some of the anticipated struggles that we would anticipate on a human level. We could talk about the rate and the volume of the G tube, but we couldn't talk about how this was going to impact a mother's sense of being able to nourish and bond and care for their child because we didn't have answers for those things. And as I went on in my journey, I realized that even if we don't have answers, it's still important for us to acknowledge those things and talk about them and be there for our patients in those conversations. Dr Smith: Well, Lauren, what a great way to end, and what a wonderful conversation, and what a great article. Congratulations and thank you. Dr Treat: Thank you, Gordon. It was a pleasure to be here. Dr Smith: Again today, I've been interviewing Dr Lauren Treat about her really great article on neuropalliative medicine in pediatric neurology practice. This article appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this issue and other issues. And thanks again to you, our listeners, for joining us today. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Limiting screentime is no longer enough to promote healthy social habits in children. ABC News Correspondent, Jim Ryan, talks about the new guidance given by the American Academy of Pediatrics.

This interview is with Ryan Clifford of Alloro Vineyard and The Allison. Ryan talks about his early life growing up in Detroit, Michigan, where he developed interests in biology, animals, and aquarium science, which later influenced in his interest in wine. Next, Ryan discusses his education and career path, including attending the American Academy of Dramatic Arts in New York City, moving to Portland, Oregon and studying wine at Chemeketa Community College, transferring to Oregon State University, and completing the WSET coursework at Linfield University.Ryan also talks about his first harvest experience in the Willamette Valley, the pandemic and how it caused him to move back to Michigan, interrupting an internship, and eventually moving back to Oregon for a job at Élevée. He now works as an assistant winemaker for Alloro Vineyard and at The Allison as a sommelier for Jory.This interview was conducted by Rich Schmidt at Alloro Vineyard in Sherwood, Oregon on January 6, 2026.

What if the future of women's longevity wasn't about fighting aging—but teaching the body how to adapt, regenerate, and thrive? In this deeply insightful episode of The Girlfriend Doctor Show, Dr. Anna Cabeca sits down with renowned longevity and regenerative medicine expert Dr. Kathleen O'Neil to unpack the cutting-edge science—and timeless fundamentals—behind women's biohacking, immune resilience, and healthy aging. Dr. O'Neil shares her extraordinary journey from pathology and the morgue to elite performance medicine, explaining how understanding why people die transformed how she helps patients live longer, stronger lives. Together, they explore immune modulation, peptides, GLP-1s, light and dark therapy, bone regeneration, adrenal health, energy medicine, and why balance—not extremes—is the true secret to longevity. From menopause and bone loss to hyperbaric oxygen therapy, peptides like oxytocin and thymosin, and the power of adaptability, this episode is a masterclass in personalized, ethical, regenerative medicine for women at every stage of life. If you're curious about biohacking beyond the hype—and want grounded, science-backed strategies that actually work—this conversation is for you.     Key Timestamps 00:01:00 – Welcome & introduction to longevity and regenerative medicine 04:05 – Dr. O'Neill's time in the morgue and what it taught her about immunity, aging, and silent disease 08:15 – The immune system explained: friend vs. foe, gut training, adaptability, and immune modulation 12:18 – Light, dark, melatonin, oxytocin & why darkness is essential for regeneration 13:19 – Feasting, fasting, and the paradoxes that build resilience and adaptability 16:04 – GLP-1s, peptides, and why dosage variability matters for long-term results 21:14 – Energy medicine, biochargers, frequency, vibration & photobiomodulation 24:10 – Adrenal burnout, cortisol dysregulation, and immune collapse 28:17 – Bone loss, ovarian aging clocks, and why prevention must start earlier 30:04 – Bone health, muscle, oxytocin & rebuilding resilience after menopause 36:17 – Regenerative medicine, stem cells, and ethical innovation in longevity care 40:41 – Inside a cutting-edge regenerative medicine clinic 41:02 – Hyperbaric oxygen therapy, lymphatic drainage & advanced recovery tools 45:18 – Personalized medicine, foundations first, adaptability & final takeaways     Memorable Quotes "Longevity is really gerotherapeutics—preventing aging by teaching the body how to regenerate." – Dr. Kathleen O'Neil "You can't hack your life without doing the fundamentals." – Dr. Kathleen O'Neil "Balance—light and dark, stress and recovery—is what creates adaptability." – Dr. Kathleen O'Neil "The immune system is a living medication inside us." – Dr. Kathleen O'Neil "Everything I do today is serving the version of myself I'll be in the future." – Dr. Anna Cabeca     Connect With Guest Dr. Kathleen O'Neil, MD Website: treatwellness.boston Instagram: @treatwellness_ About Dr. O'Neil: Dr. Kathleen O'Neil earned her M.D. from Boston University School of Medicine (Magna Cum Laude) and trained at Massachusetts General Hospital and Brigham and Women's Hospital. She is a global expert in regenerative and longevity medicine, peptide therapy, GLP-1s, and exosomes, working with elite athletes and professional teams. She is a founding board member of the International Peptide Society and the American Academy of Stem Cell Physicians and previously served as Medical Director of Tom Brady's TB12 Wellness Center.       Connect With Dr. Anna Cabeca

Fool: Identifying and Overcoming Character Deficiency Syndrome by Garry D. Nation Seriouschristian.org https://www.amazon.com/Fool-Identifying-Overcoming-Character-Deficiency/dp/1629024627 Practical wisdom…in today’s less than ethical business climate-deep, thought-provoking, and entertaining. Phil Eubanks Corporate Ethics Compliance Professional Garry is a pastor and scholar with a passion for Christ, an innovative spirit, and an open heart. I have read his work with spiritual profit. Now it’s your turn to benefit: the Bible tells us that ‘wisdom is too high for fools’ (Prov 24:7). Find out for yourself and read this book. Professor Andrew Walker King’s College, London The question of ethical character (and its deficiency) has become a matter of lively public discussion in recent years and promises to be so for a long time to come-in private life, in politics, in business, in society. While the world tries to figure out how to restore character, it will not find better guidance than we already have in the Bible. Fool: Identifying and Overcoming Character Deficiency Syndrome is a forensic, worldview-conscious study of the fool and folly as depicted in the Bible, especially in the Book of Proverbs. The message of author Garry D. Nation is that character deficiency (folly) is a vicious, predictable, downward spiral of destructive personal choices. Moral upbringing and ethics training may interrupt and temper it, but God’s grace alone can cure it. Sometimes humorous, sometimes exasperating, sometimes tragic, but always engaging, Fool uncovers surprising insights into what makes us all tick. About the author Garry D. Nation is an author, minister, scholar, educator, and speaker. He holds the B.A. magna cum laude from Oklahoma Baptist University(1975), the M.Div. (1978), and the Ph.D. (1990) from Southwestern Baptist Theological Seminary. He is a Fellow of the Oxford Society of Scholars and is a full member of the Evangelical Theological Society. His articles have been published in Christianity Today, the Mid-America Theological Journal, and the Journal for the American Academy of Ministry. Garry is also a versatile actor, singer, and perfomer. He has appeared onstage, often playing biblical characters ranging from Mordecai (Esther: For Such a Time as This) to Simon Peter (The Promise). More recently he has played lead roles in independent films such as Polycarp, Indescribable, and My Grandpa Detective.

In this episode, we turn our focus to allergic conjunctivitis. Host Paul Wirkus, MD, FAAP and Ophthalmologist Mitchell Strominger, MD guests review the clinical features of ocular allergy and discuss how characteristics such as discharge and symptom patterns can help distinguish allergic conjunctivitis from viral, bacterial, and other etiologies. The conversation also covers important mimics and red flags, including chemical conjunctivitis, corneal abrasions, and foreign bodies, with guidance on evaluation and management. This episode equips pediatricians with practical tools to accurately assess red eye complaints and determine when further intervention is needed. Have a question? Email questions@vcurb.com. They will be answered next week.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Billy Collins has contributed frequently to Rattle over the years, including an interview in issue 15. He is the author of 16 collections of poetry, including Sailing Alone Around the Room, Aimless Love and, most recently, Dog Show. He served two terms as United State Poet Laureate and is a former Distinguished Professor of English at Lehman College and New York State Poet. He is a New York Public Library Literary Lion and a member of the American Academy of Arts and Letters. He is currently “between dogs,” his most recent an Australian Shepherd mix named Jeannine. He lives in Winter Park, Florida, with his wife Suzannah. Find Dog Show here: https://www.penguinrandomhouse.com/books/790238/dog-show-by-billy-collins/ As always, we'll also include the live Prompt Lines for responses to our weekly prompt. A Zoom link will be provided in the chat window during the show before that segment begins. For links to all the past episodes, visit: https://www.rattle.com/page/rattlecast/ This Week's Prompt: Write a poem that describes the taste of a surprising food as creatively as possible. Next Week's Prompt: Write a poem about a time something was put somewhere that it didn't belong. Include an unusual detail about the person that found it. The Rattlecast livestreams on YouTube, Facebook, and Twitter, then becomes an audio podcast. Find it on iTunes, Spotify, or anywhere else you get your podcasts.

Dr. Koehler is Affinity's Medical Director and a board-certified emergency medicine physician. He has a strong interest and experience with men's and women's hormonal therapy, peptide therapy and weight loss therapy. He is also a member of the American Academy of Anti-Aging Medicine and holds a Certificate in Peptide Therapy. Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience/ Website: https://jondwoskin.com/LinkedIn: https://www.linkedin.com/in/jondwoskin/ Email: jon@jondwoskin.com Get Jon's Book: The Think Big Movement: Grow your business big. Very Big!   Connect with Dr. Koehler:Website: https://www.affinitywholehealth.com/ Twitter: https://x.com/affinitywh Instagram: https://www.instagram.com/affinitywholehealth Linkedin: https://www.linkedin.com/company/affinity-whole-health/ Facebook: https://www.facebook.com/affinitywh/                                                                         *E – explicit language may be used in this podcast.

Send us a textThis week on Neo News, we tackle the recent and controversial divergence between CDC and AAP guidelines regarding the birth dose of the Hepatitis B vaccine. With the CDC now recommending a deferred schedule for infants of Hepatitis B-negative mothers, we explore the clinical implications, the risks of vertical transmission, and the challenge of navigating discordant public health advice. We discuss how to handle shared decision-making in an era of waning vaccine confidence and why the "birth dose" remains a critical safety net in a community setting. Join us as we break down the data behind the headlines.----American Academy of Pediatrics. (2025, December 15). AAP: CDC decision on universal birth dose of hepatitis B vaccine irresponsible and purposely misleading. AAP News. https://publications.aap.org/aapnews/news/33980/AAP-CDC-decision-on-universal-birth-dose-of?searchresult=1?autologincheck=redirectedSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

What if the deepest human drive isn't happiness, survival, or even love, but the need to matter? Philosopher and MacArthur Fellow Rebecca Newberger Goldstein joins Michael Shermer to discuss The Mattering Instinct, her argument that the desire to feel significant lies at the core of human behavior. That drive helps explain our greatest achievements, from creativity and moral courage to scientific and artistic excellence. It also helps explain some of our darkest outcomes, including extremism, violence, and ideological fanaticism. Goldstein examines why people will give up comfort, status, and sometimes even their own lives to feel that they matter. She questions why meaning cannot be captured by happiness metrics or self-help formulas, and why the same psychological force can produce saints, scientists, athletes, cult leaders, and terrorists. The conversation moves through free will, entropy, morality without God, fame, narcissism, and the crucial difference between ways of mattering that create order and those that leave damage behind. Rebecca Newberger Goldstein is an award-winning philosopher, writer, and public intellectual. She is the author of ten books of acclaimed fiction and non-fiction, including 36 Arguments for the Existence of God: A Work of Fiction and Betraying Spinoza: The Renegade Jew Who Gave Us Modernity. She holds a PhD in philosophy of science from Princeton University and has taught at Yale, Columbia, NYU, Dartmouth, and Harvard. A fellow of the American Academy of Arts and Sciences, her work has been supported by the MacArthur "Genius" grant and fellowships from the Guggenheim, Whiting Institute, Radcliffe Institute, and the National Science Foundation. Her new book is The Mattering Instinct: How Our Deepest Longing Drives Us and Divides Us.

Americans have been told that working harder is the path to dignity, security, and success. But what if that promise was hijacked? This week, we're revisiting our episode with Professor Elizabeth Anderson, where she exposes how neoliberalism weaponized the “work ethic” — transforming a moral tradition that once honored workers into a system that blames them, exploits them, and rewards extraction over contribution. Drawing from her new book Hijacked, Anderson traces how today's economy punishes labor, glorifies predatory wealth, and rigs the rules against working people — and what it would take to take the work ethic back. Elizabeth Anderson is the Max Mendel Shaye Professor of Public Philosophy, Politics, and Economics at University of Michigan. She is the author of Value in Ethics and Economics, The Imperative of Integration, and Private Government: How Employers Rule Our Lives (and Why We Don't Talk about It). She is a MacArthur Fellow and Fellow of the American Academy of Arts and Sciences. Social Media: @UMPhilosophy Further reading:  Hijacked: How Neoliberalism Turned the Work Ethic Against Workers and How Workers Can Take It Back Private Government: How Employers Rule Our Lives (and Why We Don't Talk about It) Website: http://pitchforkeconomics.com Facebook: Pitchfork Economics Podcast Bluesky: @pitchforkeconomics.bsky.social Instagram: @pitchforkeconomics Threads: pitchforkeconomics TikTok: @pitchfork_econ YouTube: @pitchforkeconomics LinkedIn: Pitchfork Economics Twitter: @PitchforkEcon, @NickHanauer Substack: ⁠The Pitch⁠

At any given moment, an uncountable number of events are happening, but only some of them matter to us. What does it mean for something to matter, and more importantly, what does it mean for us to matter -- to ourselves as well as to others? The need to matter can be motivation to do great things, but it can also be a reason for people to come into conflict. Philosopher/novelist Rebecca Newberger Goldstein explores this issue in her new book The Mattering Instinct: How Our Deepest Longing Drives Us and Divides Us.Blog post with transcript: https://www.preposterousuniverse.com/podcast/2026/01/12/340-rebecca-newberger-goldstein-on-what-matters-and-why-it-matters/Support Mindscape on Patreon.Rebecca Newberger Goldstein received her Ph.D. in philosophy from Princeton University. She is the author of several novels and works of non-fiction. Among her awards are the MacArthur and Guggenheim Fellowships, membership in the American Academy of Arts and Sciences, and the National Humanities Medal.Web siteAmazon author pageWikipediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.